2023 - Research.com Medicine in Netherlands Leader Award
2023 - Research.com Immunology in Netherlands Leader Award
2022 - Research.com Immunology in Netherlands Leader Award
2012 - Member of Academia Europaea
2008 - Royal Netherlands Academy of Arts and Sciences
2006 - Spinoza Prize, Dutch Research Council
His primary areas of investigation include Immunology, Cell biology, Dendritic cell, Antigen and Immune system. His study in Immunology is interdisciplinary in nature, drawing from both Cytotoxic T cell and Cancer research, Melanoma. His Cell biology study combines topics in areas such as Molecular biology, Cell adhesion, Follicular dendritic cells and Cell–cell interaction.
His Molecular biology study integrates concerns from other disciplines, such as T lymphocyte, Monocyte, Interleukin 4, Monoclonal antibody and Interleukin 10. The concepts of his Dendritic cell study are interwoven with issues in T cell, Antigen-presenting cell, In vivo and Lymph node. His research investigates the link between Immune system and topics such as Cancer that cross with problems in Ex vivo and Pathology.
Carl G. Figdor mainly investigates Cell biology, Immunology, Immune system, Dendritic cell and Antigen. Carl G. Figdor focuses mostly in the field of Cell biology, narrowing it down to topics relating to Cell adhesion and, in certain cases, Intercellular Adhesion Molecule-1. His Immunology research integrates issues from Cytotoxic T cell and Cancer research, Melanoma.
His Immune system research incorporates themes from Cancer and Cell, Biochemistry. His studies deal with areas such as Chemokine, Major histocompatibility complex and In vivo as well as Dendritic cell. His Antigen research includes themes of Molecular biology, Antibody and Antigen presentation.
Carl G. Figdor focuses on Immune system, Dendritic cell, Immunotherapy, Immunology and Cell biology. His Immune system research is multidisciplinary, relying on both Cytotoxic T cell, Immunosuppression, Apoptosis and Antigen. His Dendritic cell study incorporates themes from Gene expression profiling, Antigen-presenting cell, CD14, Vaccination and Primary tumor.
His Immunotherapy research includes elements of Tumor microenvironment and Myeloid, Cancer research, Melanoma. Immunology is often connected to Myeloid-derived Suppressor Cell in his work. His Cell biology research incorporates elements of Cell, Tetraspanin, Receptor and Membrane protein.
His primary scientific interests are in Immune system, Immunology, Dendritic cell, Cell biology and T cell. His Immune system study combines topics from a wide range of disciplines, such as In vivo, In vitro and Antigen. His research is interdisciplinary, bridging the disciplines of Cancer and Immunology.
His studies in Dendritic cell integrate themes in fields like Myeloid and Interleukin. His biological study spans a wide range of topics, including Cell, Molecular biology, Membrane, Monocyte and Regulation of gene expression. Within one scientific family, he focuses on topics pertaining to Cytotoxic T cell under T cell, and may sometimes address concerns connected to Preclinical imaging.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
R de Waal Malefyt;J Abrams;B Bennett;C G Figdor.
Journal of Experimental Medicine (1991)
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
T.B.H. Geijtenbeek;D.S. Kwon;R. Torensma;S.J. van Vliet.
Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses
T.B.H. Geijtenbeek;R. Torensma;S.J. van Vliet;G.C.F. van Duijnhoven.
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
R de Waal Malefyt;J Haanen;H Spits;M G Roncarolo.
Journal of Experimental Medicine (1991)
Dendritic cell immunotherapy: mapping the way
Carl G Figdor;I Jolanda M de Vries;W Joost Lesterhuis;Cornelis J M Melief.
Nature Medicine (2004)
C-type lectin receptors on dendritic cells and langerhans cells
Carl G Figdor;Yvette van Kooyk;Gosse J Adema.
Nature Reviews Immunology (2002)
Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force
Katarina Wolf;Mariska te Lindert;Marina Krause;Stephanie Alexander.
Journal of Cell Biology (2013)
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
I Jolanda M de Vries;W Joost Lesterhuis;Jelle O Barentsz;Pauline Verdijk.
Nature Biotechnology (2005)
Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10.
R de Waal Malefyt;C G Figdor;R Huijbens;S Mohan-Peterson.
Journal of Immunology (1993)
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
Paul J. Tacken;I. Jolanda M. de Vries;Ruurd Torensma;Carl G. Figdor.
Nature Reviews Immunology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: